Drug Trial Radar · NCT00093886
Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)
Last checked: Nov 20, 2026Latest source record: May 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
629
Actual
Start
Apr 2004
Primary completion
Mar 2005
Study completion Apr 2005
Sponsor
- Lead sponsor
- The Medicines CompanyIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to establish the safety of clevidipine in the treatment of perioperative hypertension. Approximately 500-900 patients with perioperative hypertension undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or nitroglycerin.
Conditions
- Hypertension
Interventions
clevidipineDrug
nitroglycerinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of death, stroke, MI and renal dysfunctionTime frame: Initiation of study drug infusion through post-operative Day 30
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Brookwood Medical Center
Birmingham, Alabama
Baptist Medical Center, Montclair
Birmingham, Alabama
Medical Center East
Birmingham, Alabama
Baptist Medical Center, South
Montgomery, Alabama
University Medical Center
Tucson, Arizona
Saddleback Memorial Medical Center
Laguna Hills, California
Keck School of Medicine, University of Southern California
Los Angeles, California
Huntington Memorial Hospital
Pasadena, California
University of California
San Francisco, California
Regional Medical Center - Bayonet Point
Hudson, Florida
Health First Holmes Regional Medical Center
Melbourne, Florida
Sacred Heart Health System
Pensacola, Florida
Kaiser Permanente Moanalua Medical Center
Honolulu, Hawaii
Saint Francis Hospital
Evanston, Illinois
Wesley Medical Center
Wichita, Kansas
St Joseph Medical Center
Towson, Maryland
Henry Ford Health System
Detroit, Michigan
New York University Medical Center
New York, New York
Sterling Research Group, Ltd.
Cincinnati, Ohio
The Christ Hospital, The Linder Clinical Trial Center
Cincinnati, Ohio
Portland VA Medical Center
Portland, Oregon
Memorial Herman Memorial City Hospital
Houston, Texas
Michael E DeBakey VA Medical Center
Houston, Texas
The Methodist Hospital
Houston, Texas
Houston Northwest Medical Center
Houston, Texas
Inova Fairfax Hospital
Falls Church, Virginia
Virginia Commonwealth University Medical Center
Richmond, Virginia
Saint Joseph Medical Center
Tacoma, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.